Newsletters

03.20.20

Governor’s Executive Orders Waive Public Meeting Procedures

On March 12, 2020, Governor Newsom signed Executive Order N-25-20, a broad, far-reaching order that authorized state and local authorities to impose social distancing measures, to waive the one-week waiting period for unemployment insurance, and to suspend work hour limitations for certain ...


03.19.20

HHS Issues COVID-19 HIPAA Waivers

On March 17, HHS exercised its waiver authority under Section 1135 of the Social Security Act to waive several administrative obligations imposed on hospitals under the HIPAA Privacy Rule.


03.19.20

COVID-19: Health Plan Regulatory Issues

This document summarizes regulatory issues for health insurers, managed care entities and employment-based health plans in light of the novel coronavirus outbreak.


03.19.20

President Signs Substantially Revised Families First Coronavirus Response Bill

On March 18, 2020, the President signed into law H.R. 6201, incorporating substantial revisions to the Families First Coronavirus Response Act, which was originally passed by the House on March 14 and revised on March 16.


03.19.20

COVID-19: Evolving Cybersecurity Considerations for Businesses

Businesses’ responses to the COVID-19 health crisis, and in particular the increased demands for personnel to work remotely, present increased security risks and considerations.


03.19.20

Privacy Considerations for Navigating COVID-19

As companies develop policies and procedures to respond to the COVID-19 outbreak, company leadership would do well to consider the limitations and prohibitions on the processing of employee information under federal and state privacy laws, as well as those in any internal company policies.


03.19.20

Financial Institution Regulators Promulgate Extensive Guidance on COVID-19

While the government currently responds to the changing landscape posed by the COVID-19 virus, federal financial institution regulators are moving quickly to address multiple areas of concern posed by these unprecedented developments.


03.18.20

Pain Relief Device Marketers to Pay $4M

The marketers of a pain relief device reached a deal with the Federal Trade Commission (FTC), agreeing to pay at least $4 million and stop making the claims challenged by the agency as false and deceptive.  


03.18.20

NAD Extinguishes Spark Card Testimonials

The National Advertising Division (NAD) snuffed out Capital One’s Spark Cash Card’s use of consumer testimonials in a case brought by competitor JPMorgan Chase Bank.


03.18.20

NAD Brings Dog Supplement Claims to Heel

The marketer behind Doggie Dailies, a dietary supplement for dogs, voluntarily discontinued advertising claims for the product after an inquiry by the National Advertising Division (NAD).